655 related articles for article (PubMed ID: 21787325)
1. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
Huang Y
Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
[TBL] [Abstract][Full Text] [Related]
2. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
Huang Y
Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
[TBL] [Abstract][Full Text] [Related]
3. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
4. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
5. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E and Alzheimer disease.
Huang Y
Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
[TBL] [Abstract][Full Text] [Related]
9. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
[TBL] [Abstract][Full Text] [Related]
10. Pathological synergism between amyloid-beta and apolipoprotein E4--the most prevalent yet understudied genetic risk factor for Alzheimer's disease.
Belinson H; Michaelson DM
J Alzheimers Dis; 2009; 17(3):469-81. PubMed ID: 19363257
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
Fagan AM; Holtzman DM
Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
Lahiri DK; Sambamurti K; Bennett DA
Neurobiol Aging; 2004; 25(5):651-60. PubMed ID: 15172744
[TBL] [Abstract][Full Text] [Related]
13. Reduced levels of human apoE4 protein in an animal model of cognitive impairment.
Sullivan PM; Han B; Liu F; Mace BE; Ervin JF; Wu S; Koger D; Paul S; Bales KR
Neurobiol Aging; 2011 May; 32(5):791-801. PubMed ID: 19577821
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific proteolysis of apolipoprotein-E in the brain.
Elliott DA; Tsoi K; Holinkova S; Chan SL; Kim WS; Halliday GM; Rye KA; Garner B
Neurobiol Aging; 2011 Feb; 32(2):257-71. PubMed ID: 19278755
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies.
Huang Y
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):627-41. PubMed ID: 17002223
[TBL] [Abstract][Full Text] [Related]
16. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
Saul A; Wirths O
Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.
Huang Y
Curr Opin Lipidol; 2010 Aug; 21(4):337-45. PubMed ID: 20531185
[TBL] [Abstract][Full Text] [Related]
18. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
[TBL] [Abstract][Full Text] [Related]
20. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]